QC
TIL icon

Quadrature Capital’s Instil Bio TIL Stock Holding History

Quadrature Capital’s Portfolio TIL Stock Details TIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-19,198
Closed -$211K – 1849
2025
Q4 		$211K Buy
+19,198
New +$284K ﹤0.01% 955

Other funds holding TIL

CVV
Curative Ventures V Dallas, Texas $14.6M AUM 63.08% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
CI
CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Quadrature Capital's TIL Position: Q1 2026 in Review

Quadrature Capital sold out of Instil Bio (TIL) in Q1 2026, closing a stake of 19,198 shares — an estimated $211K sold.

Quadrature Capital first reported a position in TIL in Q4 2025 and held it in 1 quarter. The position peaked at $211K in Q4 2025. 32 funds tracked by Wall St. Rank hold TIL as of Q1 2026.

  • Quadrature Capital reported no remaining Instil Bio position as of Q1 2026 after selling out during the quarter.
  • Quadrature Capital sold 19,198 Instil Bio shares in Q1 2026, an estimated $211K.
  • Quadrature Capital first reported a position in Instil Bio in Q4 2025 and held it in 1 quarter.
  • Quadrature Capital's Instil Bio position peaked at $211K in Q4 2025.
  • 32 funds tracked by Wall St. Rank held Instil Bio as of Q1 2026.

Based on Quadrature Capital's 13F filing for Q1 2026, filed 15 May 2026.